UBS Asset Management Americas Inc. Purchases 105,452 Shares of Xylem Inc. (NYSE:XYL)

UBS Asset Management Americas Inc. increased its position in shares of Xylem Inc. (NYSE:XYL) by 10.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,150,396 shares of the industrial products company’s stock after purchasing an additional 105,452 shares during the period. UBS Asset Management Americas Inc.’s holdings in Xylem were worth $117,099,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of XYL. Profund Advisors LLC bought a new stake in Xylem in the 3rd quarter valued at $208,000. DNB Asset Management AS increased its stake in Xylem by 269.5% in the fourth quarter. DNB Asset Management AS now owns 203,126 shares of the industrial products company’s stock valued at $20,676,000 after acquiring an additional 148,159 shares during the period. Public Employees Retirement System of Ohio raised its position in Xylem by 26.8% in the fourth quarter. Public Employees Retirement System of Ohio now owns 95,925 shares of the industrial products company’s stock worth $9,764,000 after purchasing an additional 20,289 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in Xylem by 808.1% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 256,170 shares of the industrial products company’s stock worth $26,076,000 after purchasing an additional 227,960 shares during the period. Finally, Credit Agricole S A boosted its holdings in Xylem by 23.5% during the fourth quarter. Credit Agricole S A now owns 46,168 shares of the industrial products company’s stock valued at $4,699,000 after purchasing an additional 8,800 shares in the last quarter. Institutional investors and hedge funds own 84.92% of the company’s stock.

In other Xylem news, SVP Colin R. Sabol sold 5,596 shares of the stock in a transaction dated Tuesday, January 19th. The stock was sold at an average price of $104.44, for a total value of $584,446.24. Following the transaction, the senior vice president now owns 28,952 shares of the company’s stock, valued at $3,023,746.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Claudia S. Toussaint sold 5,948 shares of the firm’s stock in a transaction dated Tuesday, March 16th. The stock was sold at an average price of $102.75, for a total value of $611,157.00. Following the transaction, the senior vice president now owns 59,057 shares in the company, valued at approximately $6,068,106.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 18,392 shares of company stock valued at $1,907,808. 1.01% of the stock is owned by corporate insiders.

Several brokerages recently commented on XYL. Morgan Stanley initiated coverage on Xylem in a research note on Wednesday, March 31st. They issued an “overweight” rating and a $120.00 price target on the stock. Citigroup lowered their target price on shares of Xylem from $113.00 to $109.00 and set a “neutral” rating on the stock in a report on Friday, February 5th. Cowen downgraded shares of Xylem from a “market perform” rating to an “underperform” rating and set a $65.00 price target for the company. in a report on Friday, January 8th. Credit Suisse Group upped their price objective on shares of Xylem from $89.00 to $90.00 and gave the stock an “underperform” rating in a research note on Friday, February 5th. Finally, Stifel Nicolaus downgraded Xylem from a “buy” rating to a “hold” rating and set a $100.00 target price on the stock. in a report on Tuesday, December 15th. They noted that the move was a valuation call. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $81.46.

Shares of XYL opened at $105.94 on Thursday. The business’s fifty day moving average price is $101.95 and its two-hundred day moving average price is $97.18. The firm has a market capitalization of $19.11 billion, a price-to-earnings ratio of 76.22, a PEG ratio of 4.89 and a beta of 1.05. Xylem Inc. has a 52 week low of $56.63 and a 52 week high of $108.84. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.97 and a current ratio of 2.40.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Thursday, February 4th. The industrial products company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.13. The business had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.29 billion. Xylem had a return on equity of 14.72% and a net margin of 5.09%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.34 earnings per share. As a group, research analysts forecast that Xylem Inc. will post 1.85 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 18th. Stockholders of record on Thursday, February 18th were paid a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.06%. The ex-dividend date was Wednesday, February 17th. This is a positive change from Xylem’s previous quarterly dividend of $0.26. Xylem’s dividend payout ratio (DPR) is 37.09%.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Read More: Book Value Per Share – BVPS

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.